Research Article

Blood Leukocyte Ratios: Equivocal Parameters for Allergic Diseases

Volume: 78 Number: 1 March 31, 2025
Alper Ekinci *, Seda Altıner
EN TR

Blood Leukocyte Ratios: Equivocal Parameters for Allergic Diseases

Abstract

Objectives: Leukocytes play crucial roles in allergic and immunologic diseases. We compared neutrophil-lymphocyte ratio (NLR), basophillymphocyte ratio (BLR), eosinophil-neutrophil ratio (ENR), and eosinophil-lymphocyte ratio (ELR) in 100 drug-induced urticaria-angioedema, 100 drug/venom-triggered anaphylaxis cases, and 100 healthy controls to assess their association with the severity of the allergic reaction. Materials and Methods: Retrospective analysis of blood leukocyte counts and ratios was performed. Results: Median NLR was 1.975 in patients (2.09 in urticaria-angioedema, 1.905 in anaphylaxis) and 1.815 in controls. NLR was significantly higher in patients (p=0.038) and notably elevated in urticaria-angioedema (p=0.008). No significant differences in NLR were found between the urticaria-angioedema and anaphylaxis groups (p=0.09) or between the anaphylaxis and control groups (p=0.342). Other leukocyte ratios showed no significant changes between patient and control groups (p>0.05). Conclusion: NLR may indicate allergic responses but doesn’t have predictive value for reaction type or severity.

Keywords

Anaphylaxis, angioedema, inflammation, leukocyte, urticaria

Ethical Statement

Ethics Committee Approval: Prior to commencing the research, necessary approval was obtained from the Human Research Ethics Committee of Ankara University (approval number: i09-647-23, date: 02.11.2023). Informed Consent: Informed consent has been obtained from the participants. The investigation adhered to the Helsinki Declaration in its conduct.

References

  1. 1. Motosue MS, Li JT, Campbell RL. Anaphylaxis: epidemiology and differential diagnosis. Immunol Allergy Clin North Am. 2022;42:13-25.
  2. 2. Radonjic-Hoesli S, Hofmeier KS, Micaletto S, et al. Urticaria and angioedema: an update on classification and pathogenesis. Clin Rev Allergy Immunol. 2018;54:88-101.
  3. 3. Muraro A, Worm M, Alviani C, et al.; European Academy of Allergy and Clinical Immunology, Food Allergy, Anaphylaxis Guidelines Group. EAACI guidelines: Anaphylaxis (2021 update). Allergy. 2022;77:357-377.
  4. 4. Gibbs BF, Ennis M. Mast Cells. In: Parnham M, ed. Encyclopedia of Inflammatory Diseases. Springer; 2015:1-10.
  5. 5. Cardamone C, Parente R, Feo GD, et al. Mast cells as effector cells of innate immunity and regulators of adaptive immunity. Immunol Lett. 2016;178:10- 14.
  6. 6. Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122:474-488.
  7. 7. Brescia G, Pedruzzi B, Barion U, et al. Are neutrophil-, eosinophil-, and basophil-to-lymphocyte ratios useful markers for pinpointing patients at higher risk of recurrent sinonasal polyps? Am J Otolaryngol. 2016;37:339- 345.
  8. 8. Inokuchi-Sakata S, Ishiuji Y, Katsuta M, et al. Role of eosinophil relative count and neutrophil-to-lymphocyte ratio in the assessment of severity of atopic dermatitis. Acta Derm Venereol. 2021;101:adv00491.
  9. 9. Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13:100472.
  10. 10. Cerci P, Ucan A. Assessing anaphylaxis risk: a study on basophil-tolymphocyte and eosinophil-to-lymphocyte ratios as predictive biomarkers. Asthma Allergy Immunol. 2023;21:135-142.
APA
Ekinci, A., & Altıner, S. (2025). Blood Leukocyte Ratios: Equivocal Parameters for Allergic Diseases. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 78(1), 13-19. https://doi.org/10.4274/atfm.galenos.2025.62593
AMA
1.Ekinci A, Altıner S. Blood Leukocyte Ratios: Equivocal Parameters for Allergic Diseases. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2025;78(1):13-19. doi:10.4274/atfm.galenos.2025.62593
Chicago
Ekinci, Alper, and Seda Altıner. 2025. “Blood Leukocyte Ratios: Equivocal Parameters for Allergic Diseases”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 78 (1): 13-19. https://doi.org/10.4274/atfm.galenos.2025.62593.
EndNote
Ekinci A, Altıner S (March 1, 2025) Blood Leukocyte Ratios: Equivocal Parameters for Allergic Diseases. Ankara Üniversitesi Tıp Fakültesi Mecmuası 78 1 13–19.
IEEE
[1]A. Ekinci and S. Altıner, “Blood Leukocyte Ratios: Equivocal Parameters for Allergic Diseases”, Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 78, no. 1, pp. 13–19, Mar. 2025, doi: 10.4274/atfm.galenos.2025.62593.
ISNAD
Ekinci, Alper - Altıner, Seda. “Blood Leukocyte Ratios: Equivocal Parameters for Allergic Diseases”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 78/1 (March 1, 2025): 13-19. https://doi.org/10.4274/atfm.galenos.2025.62593.
JAMA
1.Ekinci A, Altıner S. Blood Leukocyte Ratios: Equivocal Parameters for Allergic Diseases. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2025;78:13–19.
MLA
Ekinci, Alper, and Seda Altıner. “Blood Leukocyte Ratios: Equivocal Parameters for Allergic Diseases”. Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 78, no. 1, Mar. 2025, pp. 13-19, doi:10.4274/atfm.galenos.2025.62593.
Vancouver
1.Alper Ekinci, Seda Altıner. Blood Leukocyte Ratios: Equivocal Parameters for Allergic Diseases. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2025 Mar. 1;78(1):13-9. doi:10.4274/atfm.galenos.2025.62593